Skip to content

Yourgene Genomic Services portfolio expansion

Cytox’s genoSCORETM-LAB test can predict the risk of developing Alzheimer’s disease Yourgene Genomic Services to run the array-based test at Citylabs 1.0 in Manchester Manchester, UK – 11 March 2021: Yourgene (AIM: YGEN), the international molecular diagnostics group, announces that Yourgene Genomic Services (“YGS”) has signed a contract with Cytox Ltd (“Cytox”), a collaborative partner, to … Continued

Open Orphan wins contract with Oxford Biotherapeutics

Open Orphan plc (AIM: ORPH), a rapidly growing specialist pharmaceutical services CRO and a world leader in vaccine and antiviral testing using human challenge clinical trials, announces its subsidiary Venn Life Sciences (“Venn”) has been awarded a contract for a study with Oxford BioTherapeutics, a clinical stage oncology company with a pipeline of immune-oncology and antibody-drug conjugate-based therapies. This … Continued

Celebrating Women in Leadership

Today, on International Women’s Day 2021, we join companies around the globe celebrating the social, economic, cultural, and political achievements of women. International Women’s Day #IWD2021 is an annual reminder to not only recognise and champion greater female representation but also to accelerate gender parity. For this year’s theme #ChooseToChallenge, we believe Calculus leads by … Continued

Support for the creative industries

The creative sector makes a remarkable contribution to the UK economy It is integral to the UK’s economic and social regeneration £400m budget bonus to support the arts British stars dominated at Sunday evening’s Golden Globes virtual awards ceremony with The Crown taking several awards and Sacha Baron Cohen and John Boyega also scooping top … Continued

Calculus VCT – zero initial fee offer

Normal initial fees of 3-5% waived for a limited period in the run up to the end of the tax year. Award-winning Enterprise Investment Scheme (EIS) and Venture Capital Trust (VCT) specialist, Calculus Capital, is waiving initial fees on its VCT until the end of March. Calculus is looking to raise £10 million which it will … Continued

Open Orphan: World’s first COVID-19 human trials given green light in the UK

Open Orphan plc, a rapidly growing specialist pharmaceutical services clinical research organisation (CRO) and world leader in vaccine and antiviral testing using human challenge clinical trials, announced the world’s first COVID‐19 characterisation study has received approval from a specially convened Research Ethics Committee (“REC”). This news follows the announcement on 20 October 2020 of Open … Continued

Avacta and Mologic announce commercial partnership

By working together over the next few months they aim to accelerate to market Avacta’s AffiDX™ SARS-CoV-2 lateral flow rapid antigen test. They will CE mark it for professional use under Mologic’s existing ISO13485 quality system.  The CE mark will then be transferred to Avacta when it receives ISO13485 accreditation, which is expected by the … Continued

Calculus invests in eConsult

eConsult Health is the leading online consultation provider to the NHS for primary care With considerable growth over the last year the platform is now live in over 3,200 NHS GP practices and gives millions of patients access to their own GP online. The funding round will be used to accelerate growth in primary care … Continued

Naomi Watts to headline new film produced by Maven Screen Media

Naomi Watts is set to headline “Infinite Storm,” the highly anticipated film from Polish director Malgorzata Szumowska. “Infinite Storm” is being produced by Maven Screen Media’s Celine Rattray, Trudie Styler and Jenny Halper with Naomi Watts for JamTart Productions, as well as Peter and Michael Sobiloff. Calculus invested in Maven Screen Media in August 2020. Specifically, Maven … Continued